Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
By H. Gerstein, JohannesF. E. Mann, Q. Yi, B. Zinman, S. Dinneen, B. Hoogwerf, J. Hallé, James B. Young, A. Rashkow, C. Joyce and 2 more. Journal of the American Medical Association (JAMA), 2001
2,310 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Nephrology
View Paper: https://www.semanticscholar.org/paper/3c66192ec721a7d97f6f1c10f7ddbf401c4ad02a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- P. Whelton
- D. Rothenbacher
- J. Griffith
- E. Schiffrin
- A. Levey
- H. Tighiouart
- Giuseppe Remuzzi
- V. Basevi
In Nephrology
- D. Rothenbacher
- Josef Coresh
- A. Levey
- Marcello Tonelli
- Giuseppe Remuzzi
- L. Stevens
- Qiu-li Zhang
- Tom Greene
Citations in the corpus
- Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study (2003, background): “The Heart Outcomes and Prevention Evaluation (HOPE) study (16), which recruited patients with various cardiovascular diseases and risk factors but not necessarily hypertension, found an almost 2-fold increase in the primary end point in patients with a UACR greater than 1.”
- Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. (2002, background): “5 yr of follow-up monitoring of patients enrolled in a clinical trial (25).”
- Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. (2005, methodology): “important tool for identifying those at increased risk for atherosclerotic vascular disease [13].”
- The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “In both diabetic and nondiabetic hypertensive patients, microalbuminuria, even below the threshold values usually considered [216], has been shown to predict CV events [217–225], and continuous relationships between CV, as well as non-CV mortality and urinary albumin/creatinine ratios >3.”